Anandamide: a candidate neurotransmitter heads for the big leagues.
Self
D W
DW
D000339:Affect / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001095:Arachidonic Acids / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D063388:Endocannabinoids; D005989:Glycerides / Q000502:physiology; D006948:Hyperkinesis / Q000139:chemically induced; D008564:Membrane Potentials; D009043:Motor Activity / Q000502:physiology*; D053284:Polyunsaturated Alkamides; D051381:Rats; D043882:Receptors, Cannabinoid; D017448:Receptors, Dopamine D2 / Q000502:physiology*; D011955:Receptors, Drug / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology
D001095:Arachidonic Acids; D063388:Endocannabinoids; D005989:Glycerides; D053284:Polyunsaturated Alkamides; D043882:Receptors, Cannabinoid; D017448:Receptors, Dopamine D2; D011955:Receptors, Drug; C094503:glyceryl 2-arachidonate; C078814:anandamide